Novel French antidepressants not available in the United States

There is little awareness in the United States and other English-speaking countries of a number of novel antidepressant drugs that have recently been developed and marketed in France. This review focuses on tianeptine, amineptine, minaprine, medifoxamine, and modafinil--examining both their pharmacological actions and their clinical efficacies. Their potential for further research or marketing in the United States is discussed.